Background
Methionine and cysteine are considered to be the principal sulfur-containing amino acids in proteins, and they play critical roles in cell metabolism. Methionine aids in the breakdown of fats by both preventing their accumulation in the arteries [
1], aiding the digestive system and facilitating the elimination of heavy metals from the body, which can be converted into cysteine to prevent toxic damage in the liver. Methionine is also an important antioxidant because its sulfur group can inactivate free radicals [
2‐
5], and it is one of the three amino acids that the body needs to produce creatine, which is an essential compound for energy production and muscle building [
6]. In addition, it may be useful in the treatment of depression [
7,
8]; some studies have indicated that methionine might improve memory recall and suggested a key role for this aminoacid in brain processes. Methionine deficiencies can trigger several alterations, such as fatty liver, slow growth, weakness, edema and skin lesions [
9,
10]. Conversely, severe methionine deficiency might cause dementia [
11]. Although methionine is a key amino acid for humans [
12,
13], there is evidence that excessive uptake can become harmful [
9,
10].
Methionine metabolism begins with its conversion to homocysteine (Hcy) via its intermediate, S-adenosyl-methionine (SAM). This sequence of reactions is called transmethylation, and it ubiquitously occurs in mammalian cells [
14]. Then, Hcy is removed by its combination with serine to produce cystathionine, which is cleaved to form α-ketobutyrate and cysteine. Additionally, homocysteine may be methylated back to methionine by methionine synthase (MS) [
15]. High levels of homocysteine are associated with diverse illnesses, such as cardiovascular and cerebrovascular disease, renal dysfunction, and dementia [
16‐
18]. Similarly, a diet rich in methionine, which is an amino acid typically found in fish, beans, red meat, eggs, garlic, lentils, onions, yogurt and seeds, can cause deleterious effects on one’s health [
19]. Several researchers have linked the consumption of both unprocessed and processed red meat with a higher risk of developing Type 2 diabetes [
20], heart disease, and certain types of cancer [
21]. Interestingly, it has been reported that the high consumption of methionine could promote brain damage. In the past, the transmethylation theory of schizophrenia was proposed, based on the fact that methyl donors such as methionine can exacerbate psychotic symptoms [
22‐
25]. Additionally, recent clinical studies link high levels of plasma methionine sulfoxide, an intermediate in the methionine cycle, with ageing and Alzheimer’s disease (AD) [
26,
27]. Furthermore, long-term exposure to high levels of methionine induces memory deficit in zebrafish [
28]; however, a detailed analysis of the effects of a methionine-rich diet on the hippocampus, a structure essential to learning and memory, has not been carried out in wild-type mice. Overall, although methionine is a key aminoacid in humans [
26,
27], a large body of evidence supports the notion that excessive uptake can become harmful, further clarifying that the way we eat is fundamental in a healthy lifestyle.
In the present study, we performed a detailed analysis to determine the effects of a high methionine diet in wild-type mice on hippocampal structure and function. We treated wild-type C57/BL6 mice for 12 weeks with 8.2 g/kg of L-methionine, a dosage twice the concentration found in a normal diet [
29,
30]. Then, the animals were subjected to different behavioral tests. Next, brain slices were obtained to evaluate different histopathological markers of AD using both immunohistochemical and biochemical analyses. Our results showed that the brains of mice with a methionine-rich diet presented 1) increased levels of phosphorylated
tau protein, 2) increased levels of amyloid-β (Aβ) peptides and Aβ oligomers, 3) neuroinflammation, 4) increased levels of nitro-tyrosinated protein, a marker of oxidative stress, 5) decreased levels of pre- and post- synaptic proteins, and 6) memory impairment accompanied by the loss of function of the
Wnt signaling pathway. Taken together, these results suggest that a methionine-enriched diet triggers neurotoxic effects
in vivo and might contribute to the appearance of Alzheimer’s-like neurodegeneration.
Discussion
In the present work, we found that animals treated with an L-methionine-enriched diet exhibited an increase in the levels of Aβ1-42 peptide and its aggregation as well as increased tau phosphorylation, both hallmarks of AD. In addition, we found increased levels of neuroinflammation, oxidative stress and decreased synaptic proteins. Consistent with these effects, the L-methionine treated animals also showed clear cognitive deficits. Finally, for the first time, we described a loss in the components of the canonical Wnt signaling pathway. Together, these data demonstrate that increasing the levels of L-methionine intake might contribute to the development of Alzheimer’s-like neurodegeneration.
This is the first study to utilize chronic treatment with L-methionine for 12 weeks in wild-type mice and thereby focus on the neurobiological effects of L-methionine and its association with neurodegeneration, such as the one observed in AD. A few other studies regarding these effects have been published, although they were not as detailed as in this work and were not conducted in wild-type mice. Using a wide variety of experimental tools, we concluded that hyper-methioninemia has important neurotoxic effects on hippocampal components and function with characteristics of AD in wild-type mice.
In animals fed with an enriched methionine diet, we detected higher levels of
tau phosphorylation and Aβ peptide load in hippocampal lysates. Because both features are considered hallmarks of AD, this finding led us to propose that L-methionine causes an AD-like disease. These data could explain the loss of synaptic proteins (Fig.
5) and the memory impairments (Fig.
6) described previously; however, we must be cautious because we cannot confirm that there is a causal relationship, only that there is a high correlation. According to the amyloid hypothesis, the production, aggregation and accumulation of Aβ peptides are the main features responsible for AD; [
62], therefore, these processes could have triggered the synaptic failure, oxidative stress and neuroinflammation observed here. Interestingly, in the L-methionine-treated mice, only the epitopes T231 and S235 of the
tau protein presented an increase in their phosphorylated levels (Fig.
1), whereas PHF1 and AT8 were unaffected. These epitopes, T231 and S235, have been associated with the triggering process of
tau aggregation into neurofibrillary tangles [
35]. In contrast, AT8 and PHF1 are associated with the process of aggregation and accumulation of paired-helical filaments that form the neurofibrillary tangles [
63]. These results suggest that L-methionine would deregulate
tau kinases or phosphatases, thereby favoring the dissociation of
tau from the microtubules, which is an initial process in the early stage of AD.
As mentioned previously, one of the key aspects of AD corresponds to Aβ peptide accumulation and the formation of Aβ oligomeric structures [
64]. In our results, we observed an increase in both the Aβ species levels and Aβ oligomers (Aβo) presence in the hippocampi of animals treated with a diet high in L-methionine compared with control mice (Fig.
2). One intriguing aspect was the fact that our results show an increase in the Aβ
40 and Aβ
42 species levels on the hippocampus of L-methionine mice by using two different kits and also demonstrate the presence of 54-KDa Aβ species, which have been described as synaptotoxic Aβo structures (Fig.
2e), and this could have been the main triggering factor for the memory loss observed in these treated animals (Fig.
1). However, we were not able to visualize Aβ plaques in the Th-S staining of brain slices from any group of animals (data not shown). We attributed this result to the fact that wild-type rodents are not able to form senile plaques unless they are induced by an exogenous nucleating factor, such as acetylcholinesterase [
65]. Previous studies showed that in an APP mice model of AD, consumption of a methionine-rich diet for 10 weeks increased the levels of total brain Aβ peptide and phosphorylated
tau in the brain [
34]. However, those authors did not study a specific brain region, and our results were obtained specifically in the hippocampus; moreover, we treated the animals for 12 weeks instead of 10. These variables and the differences in the time periods probably explained the minor differences between our results.
It is known that the augmented nitrotyrosine content in proteins is related to neurodegenerative diseases such as Parkinson’s, amyotrophic lateral sclerosis, and AD [
66]. S-nitrosylation (SNO) is a post-translational modification caused by nitric oxide radicals reacting with cysteine thiols [
42]. Here, we examined the total levels of protein nitrotyrosylation. In previous studies, Foster et al. [
67] described a considerable number of proteins that suffered increased nitrosylation in AD [
67,
68]. In fact, drugs that decrease SNO, such as deprenyl and rosiglitazone, have been reported to ameliorate Type2 diabetes and neurodegeneration. Interestingly, our group previously reported the beneficial effects of rosiglitazone in a transgenic mouse model of AD [
50]. Although we did not investigate the cause of the SNO increase in the present study, a possible explanation for this increase might be related to the over-activation of the NMDA receptor: it has been found that the over-activation of this receptor causes deregulation in SNO, which is an interesting fact in the context of neurodegenerative diseases. This increase in SNO correlates with the increased astrocyte (GFAP) and microglia activation (Cd11b), which indicates neuro-inflammatory response; this relationship has been described separately by different groups [
69].
Moreover, when different synaptic proteins were evaluated, we found that VGluT1, SYN, PSD-95 and GluA2 proteins were diminished in hippocampal extracts from animals with chronic treatment with L-methionine (Fig.
4). These results are consistent with studies that have demonstrated a decrease in synaptic proteins in brain samples from schizophrenic patients [
48] and the loss of dendritic spines caused by L-methionine treatment [
47]. Similar decreases have been reported in the hippocampus and cortex of double transgenic mice models of AD [
49,
50,
70].
Synaptic plasticity, specifically at the hippocampus, has been strongly related to memory acquisition [
71]. To evaluate memory, we conducted two different tests that evaluate hippocampus-dependent memory: the Morris water maze to test spatial memory flexibility and the Novel object recognition test to evaluate contextual memory. The memory flexibility tests showed that the L-methionine group was constant in its performance over all days, whereas the control group constantly decreased the number of trials required to reach the criterion. Because the average velocity was not different between groups, we can discard any motor activity failure caused by the treatment. Impairments in both spatial and contextual memory were observed in the L-methionine-treated group, as shown by the significant reduction in the novel recognition index. Anxiety and motor activity impairment were completely discarded by the results of the open field test, in which there was no significant difference between the control and L-methionine groups (Fig.
6). The increase in the production and aggregation of Aβ, together with the increased level of oxidative stress, inflammation,
tau phosphorylation and loss of
Wnt signaling, can explain the memory failure observed in the L-methionine group.
With respect to methionine, is important to recall that its metabolic product is homocysteine, the levels of which also increase with a high methionine diet [
72]. Thus, homocysteine might have had a significant role in this alteration. Homocysteine is an aminoacid that is not present in the diet, and it can only be synthesized from methionine or another intermediate of the methionine cycle. This cycle begins with the addition of adenosine to the sulfur group of methionine by methionine adenosyltransferase (MAT), which activates the adjacent methyl group to form S-Adenosyl Methionine (SAM). Then, the process continues with the removal of the previously activated methyl group of SAM to produce S-Adenosyl Homocysteine (SAH), which is performed by the Zn-dependent methyl transferase, an enzyme that is responsible for important methylations of DNA and other molecules. Subsequently, the S-Adenosyl Homocysteine Hydrolase (SAHH) removes the adenosine molecule of SAH, which is converted into Homocysteine (Hcy) [
73]. When this metabolism is disrupted and in the case of an overload of L-Methionine, many alterations could occur, such as Hiperhomocysteinemia, which is a condition that is characterized by high levels of homocysteine in the blood and is present in several disease conditions [
74]. Moreover, several studies have found a correlation between hyperhomocysteinemia and AD [
75,
76]. Unfortunately, the mechanism by which homocysteine is involved in AD is still unclear. There is some evidence that it could be involved in oxidative stress [
77], endoplasmic reticulum stress [
78] neuronal DNA damage [
79], the enhancement of β-amyloid peptide-mediated vascular smooth muscle toxicity, demethylation [
80] or Aβ elevation [
81].
Nonetheless, it is not only homocysteine that can alter neural function: another metabolite of methionine cycle that can also participate is S-adenosylhomocysteine (SAH). SAH binds to methyltransferase enzymes, which causes their inhibition [
82]. This inhibition could involve the Aβ peptide because the gene of the amyloid precursor protein (APP) is highly methylated, and it has been observed that a decrease in these methylations promotes the extracellular deposition of Aβ peptides [
83]. In fact, new studies show that the inhibition of protein phosphatase 2A methyltransferase (PPMT) caused by hyperhomocysteinemia promotes
tau and leads to APP deregulation [
84]. Moreover, it is also known that homocysteic acid, an agonist for N-methyl-D-aspartate (NMDA) but a partial antagonist of the glycine coagonist site, can be responsible for some alterations, such as excitotoxicity and apoptosis [
85]. Given these findings, we cannot affirm that all the effects observed with a high methionine level are caused by an increase in the levels of homocysteine or its related metabolites.
A strong relationship between the loss of function of
Wnt signaling and the neuronal dysfunction observed during AD progression has been established [
56,
70,
86‐
88]. Several studies have demonstrated that
Wnt signaling components are altered in the AD brain: (1) β-catenin levels are reduced in patients carrying presenilin-1-inherited mutations [
89]; (2) Exposing cultured hippocampal neurons to exogenous Aβ results in the inhibition of canonical
Wnt signaling [
90]; (3) Dickkoff-1 (
Dkk1), a
Wnt antagonist, is induced by Aβ in hippocampal neurons [
87] and is able to reduce the amount of synaptic proteins [
91]; (4) apo-lipoprotein E (apoEε4), a major genetic risk factor for AD, inhibits canonical
Wnt signaling [
92]; (5) a common genetic variation within the low-density lipoprotein receptor-related protein 6 (LRP6) leads to AD progression [
93]; a decrease in LRP6 levels is observed in AD patients [
94]; and (6) there are certain polymorphisms in the clusterine gene, according to GWAS, that may modulate the risk for late-onset AD [
95], and induces
Dkk-1 expression [
88]. Therefore, considering the above roles of
Wnt signaling, it is highly possible that a decrease or deregulation of its components may contribute to the synaptic dysfunction that is characteristic of early stages of AD [
70,
96]. In addition, canonical
Wnt signaling regulates hippocampal development, synaptogenesis and synaptic plasticity [
96,
97]. Canonical ligands are released, and their levels are regulated by synaptic activity in the hippocampus, which suggests an essential role for canonical
Wnt signaling in the process of learning and memory [
98-
100]. Indeed, other studies have demonstrated that canonical
Wnt signaling is necessary for hippocampal object recognition memory consolidation [
58]. In the present work, a high-methionine diet caused a decrease in β-catenin and the inhibition of GSK-3β activity. Moreover, a reduction in the protein levels of the
Wnt target genes cyclin-D1 and c-jun was observed, which indicated a decrease in the activity of the entire
Wnt signaling pathway (Fig.
7). These results suggest that L-methionine induces a loss of
Wnt signaling function, a situation reminiscent of what has been observed in AD [
70,
88,
101].
Authors’ contributions
Study concept and design: CTR, CBL, CMO, MSA, DB, SH, NCI. Acquisition of data: CTR, CBL, CMO, MSA, RMR. Analysis and interpretation of the data: CTR, CBL, CMO, MSA, DB, SH, NCI. Drafting of the manuscript: CTR, CBL, MSA, CMO, NCI. Statistical analysis: CTR, CBL, CMO. Critical revision of the manuscript for intellectual content: CTR, CBL, DB, SH, NCI. All authors read and approved the final manuscript.